Stryker Corp. (SYK)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Stryker Corp. (SYK)
Go deeper and ask any question about SYK
Company Performance
Current Price
as of Oct 03, 2024$351.61
P/E Ratio
39.21
Market Cap
$133.99B
Description
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Metrics
Overview
- HQPortage, MI
- SectorHealth Technology
- IndustryMedical Specialties
- TickerSYK
- Price$351.61-0.99%
Trading Information
- Market Cap$133.99B
- Float93.84%
- Average Daily Volume (1m)1,051,354
- Average Daily Volume (3m)1,212,894
- EPS$9.07
Company
- Revenue$21.39B
- Rev Growth (1yr)8.53%
- Net Income$825.00M
- Gross Margin61.31%
- EBITDA Margin26.12%
- EBITDA$1.42B
- EV$141.92B
- EV/Revenue6.64
- P/E39.21
- P/S6.34